Enforcement Decree Of The Pharmaceutical Affairs Act
전체선택
Article 1 (Purpose)
Article 2 (Implementation of National Examination for Pharmacists and Herb Pharmacists and Preliminary Examination for Pharmacists)
Article 3 (Application for National Examination)
Article 4 (Examination Subjects)
Article 5 (Determination of Passing the Exam)
Article 6 (Announcement of Successful Candidates)
Article 7 (Examiners)
Article 8 (Request for Cooperation to Relevant Agencies)
Article 8-2 (Composition of Ethics Committee)
Article 8-3 (Operation of Each Ethics Committee)
Article 8-4 (Exclusion of Members of Ethics Committee)
Article 9 (Authorization for Establishment of Pharmaceutical Association and Oriental Pharmacy Association)
Article 10 (Matters to Be Included in Articles of Association)
Article 11 (Application for Authorization for Modification of Articles of Association)
Article 12 (Establishment of Chapters)
Article 13 (Functions of the Central Pharmaceutical Affairs Advisory Committee)
Article 14 Deleted.
Article 14-2 (Dismissal of Members of the Advisory Committee)
Article 14-3 (Disqualification of, Challenge to, and Refrainment by, Council Members)
Article 15 (Duties of Chairperson)
Article 16 (Convocation of Meetings)
Article 17 (Subcommittees)
Article 18 (Proceedings)
Article 19 (Reporting)
Article 20 (Research Committee Members)
Article 20-2 (Hearing of Opinions)
Article 21 (Executive Secretary and Clerks)
Article 22 (Allowances and Traveling Expenses)
Article 22-2 (Standards for Facilities of Pharmacies)
Article 23 (Scope of Direct Dispensing by Physicians or Dentists)
Article 24 (Similar Collusive Acts)
Article 24-2 (Entrustment of Affairs of Registrating Drug Identification Mark)
Article 25 (Examination for Herb Druggists)
Article 26 (Eligibility Requirements for Examination)
Article 27 (Subjects of Examination and Allotting Percentage)
Article 28 (Public Announcement of Examination)
Article 29 (Application Form)
Article 30 (Determination of Successful Applicants)
Article 31 (Examination Committee Members)
Article 31-2 (Standards for Facilities of Herb Druggists and Drug Wholesalers)
Article 32 (Grounds for Retail or Distribution of Drugs by Persons Who Obtained Permission by Item of Drugs)
Article 32-2 (Designation of Korea Pharmaceutical Information Service)
Article 32-3 (Operation of Korea Pharmaceutical Information Service)
Article 32-4 (Fees for Providing Drug Distribution Information)
Article 32-5 (Grounds for Exceptions to Informing of Application for Permission by Item)
Article 32-6 (Entrustment of Affairs of Deliberation on Advertisement)
Article 32-7 (Organization and Operation of the Korea Institute of Drug Safety and Risk Management)
Article 32-8 (For-Profit Projects)
Article 32-9 (Approval of Business Plans and Budget Bills)
Article 32-10 (Documents for Access or Inspection by Drug Epidemiological Investigators)
Article 32-11 (Instructions for Entry, Inspection, and Collection)
Article 32-12 (Informing Relevant Agencies)
Article 33 (Standards for Calculation of Penalty Surcharges Imposed in Lieu of Disposition of Business Suspension)
Article 34 (Procedures for Imposition and Collection of Penalty Surcharges Imposed in Lieu of Disposition of Business Suspension)
Article 34-2 (Disposition to Defaulters of Penalty Surcharges Imposed in Lieu of Disposition of Business Suspension)
Article 34-3 (Standards for Imposing Penalty Surcharges for Manufacturing of Hazardous Drugs)
Article 34-4 (Imposition and Payment of Penalty Surcharges for Manufacturing of Hazardous Drugs)
Article 34-5 (Extension of Deadline for Payment of Penalty Surcharges for Manufacturing of Hazardous Drugs, and Installment Payment)
Article 34-6 (Demand for Payment of Penalty Surcharges for Manufacturing of Hazardous Drugs)
Article 34-7 (Designation of Professional Training Institution)
Article 34-8 (Functions of Council for Stable Supply of National Essential Drugs)
Article 34-9 (Organization of Council)
Article 34-10 (Operation of Council)
Article 34-11 (Working Committee and Subcommittees)
Article 34-12 (Executive Secretary)
Article 34-13 (Allowances)
Article 35 (Delegation and Entrustment of Affairs)
Article 36 (Special Cases concerning Animal Drugs, etc.)
Article 36-2 (Field Survey Documents for Investigation and Evaluation of Injury from Side Effects of Drugs)
Article 37 (Procedures for Paying Monetary Awards)
Article 38 (Operation of the Korea Orphan and Essential Drug Center)
Article 38-2 (Handling of Sensitive Information and Personally Identifiable Information)
Article 38-3 (Re-Examination of Regulation)
Article 39 (Imposition and Collection of Administrative Fines)